Privately owned biotech company Symphogen has chosen TransPerfect Life Sciences’ Trial Interactive (TI) GlobalLearn learning management system to simplify learning in clinical trials.

Symphogen is engaged in advancing superior monoclonal antibodies (mAb) therapeutics for oncology and immuno-oncology.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The system will allow Symphogen to provide critical compliance-focused training programmes to research personnel. This will help in meeting regulatory standards, as well as meet the expectations of the Food and Drug Administration (FDA) and sponsors.

The company noted that study personnel are required to ensure effective knowledge transfer on protocols, amendments, and other critical study content.

Symphogen has selected TI GlobalLearn for its clinical research compliance and the effective creation and remote training rollout.

TransPerfect’s TI e-clinical platform provides end-to-end clinical research lifecycle solutions, including site selection and activation, clinical content collaboration, and e-learning.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

By combining compliance learning and content collaboration, TI GlobalLearn enables sponsors and contract research organisations (CROs) to increase savings in study training logistics.

According to TransPerfect, this integrated experience creates a streamlined process from clinical document authoring, review and approval, to training delivery to archival in the electronic trial master file (eTMF).

TransPerfect president and CEO Phil Shawe said: “Symphogen is a forward-thinking organisation and is continually building its culture of quality and inspection readiness.

“GlobalLearn enhances the e-clinical experience by ensuring that the knowledge necessary to conduct studies efficiently and within the framework of regulatory compliance is shared among all relevant stakeholders.”